Laddar...
Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma
Neurofibromatosis type 2 (NF2) is a tumor suppressor gene syndrome characterized by multiple schwannomas, especially vestibular schwannomas (VS), and meningiomas. Anticancer drug trials are now being explored, but there are no standardized endpoints in NF2. We review the challenges of NF2 clinical t...
Sparad:
| Huvudupphovsmän: | , , , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2009
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4036446/ https://ncbi.nlm.nih.gov/pubmed/19430883 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-009-9867-7 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|